GLTO
Galecto, Inc.
NASDAQ · Healthcare · Biotechnology · US
$21.58
−3.36%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-46.1%
Return on equity
-43.9%
Return on assets
-46.7%
Return on invested capital
0.00x
Asset turnover
-$24.9M
Cash from operations
$402
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026